MedTech
Interim Leadership for MedTech
MedTech
Nextt & Mason places proven interim leaders into MedTech companies across the Nordics - fast, regulation-ready and built for quality and patient safety.
A MedTech company cannot pause for a leadership vacancy. When a Head of Quality, Regulatory Affairs, COO, or CEO role opens in a medical device business, Nextt & Mason places a proven interim leader within days, not the six to nine months a traditional search takes. Everything you sell sits inside a regulated system. A gap at the top is not an internal matter - it is an audit, compliance, and patient-safety risk.
Contact us if you need an interim leader
Why MedTech Demands a Different Kind of Leadership
Leading a medical technology company is not the same discipline as leading a commercial enterprise in an unregulated market. Five pressures define the environment, and every interim leader we place has already led through them:
- Regulation that keeps moving. MDR, IVDR, ISO 13485, and FDA requirements overlap, evolve, and are enforced through audits and notified body reviews. Leaders must keep certifications intact while the rules keep shifting.
- Quality and patient safety first. In MedTech, quality is the licence to operate. Post-market surveillance, complaint handling, and field corrective actions must stand up to scrutiny - and a single failure can reach a patient.
- Long development cycles and clinical evidence. Products take years to design, validate, and clear, and evidence requirements keep rising. Leaders must plan and fund programmes with horizons far beyond a single budget year.
- Market access and reimbursement. Hospitals, tenders, and reimbursement systems differ from country to country. A strong device without a market access strategy does not reach the patients who need it.
- Software, supply chain, and scale. Software as a medical device, cybersecurity, and single-source components add new risk to every launch - while growth, new ownership, or an acquisition demands that the organisation scales without losing control of quality.
The Situations We Recognise
Our clients in MedTech come to us at moments of acute pressure. The triggers vary, the underlying need is always the same: the right leader, immediately.
- A Head of Quality or Regulatory Affairs leaves just ahead of a notified body or FDA audit
- A critical audit finding or field safety corrective action needs experienced leadership on the ground
- A transition to MDR or IVDR stalls because the internal capacity to run it isn't there
- A founder-led business scales into commercial operations and needs a structure it has never had
- A private equity acquisition or merger requires a leader to integrate quality systems and hold the organisation together
- A launch into a new market needs a leader who knows regulatory, reimbursement, and distribution from day one
In every one of these situations, Nextt & Mason has been here before. We know what is at stake. We know how to close the gap - fast.
Contact us if you need an interim leader
What Our Interim Leaders Deliver
An interim leader from Nextt & Mason does not arrive to observe. They step in with authority, assess with speed, and start delivering from day one. Across MedTech, our leaders have led organisations through:
- Regulatory strategy and submissions — planning and driving CE marking, MDR and IVDR transitions, and FDA submissions against a realistic timeline
- Quality system and audit readiness — building and repairing QMS foundations under ISO 13485, so audits become routine rather than a crisis
- Clinical and evidence strategy — structuring clinical investigations and post-market evidence that support both approval and adoption
- Market access and commercial launch — turning regulatory approval into hospital adoption and reimbursement
- Operations and supply chain resilience — securing components, suppliers, and production through growth and disruption
FAQ - MedTech
What is interim leadership in MedTech?
It means placing an experienced senior executive into a medical device, diagnostics, or health technology company on a time-limited basis to fill a leadership gap, secure compliance, or drive a specific outcome such as an audit, a certification, or a launch. Given the regulatory and patient-safety stakes involved, these leaders must be effective from day one.
How fast can Nextt & Mason place an interim leader in a MedTech company?
Nextt & Mason places interim leaders within days of a briefing. Our network includes executives with direct experience from medical devices, diagnostics, and health technology across the Nordics and internationally, so the match is precise rather than approximate.
Why is interim leadership particularly valuable in MedTech right now?
Regulatory workload under MDR and IVDR, long certification timelines, and strong competition for experienced quality and regulatory leaders have created acute demand - while traditional recruitment for these roles takes six to nine months. Interim leadership delivers a proven leader within days, which is often the only realistic option ahead of an audit or deadline.
What functions can interim leaders cover in MedTech?
Nextt & Mason places interim leaders across all senior functions - including CEO, COO, CFO, Head of Quality, regulatory affairs, clinical affairs, product development, operations, supply chain, commercial and market access, and digital and IT.
How do interim leaders handle regulatory complexity in MedTech?
Our interim leaders bring direct experience operating inside frameworks such as MDR, IVDR, ISO 13485, and FDA requirements. They know how to keep certifications and audits on track without losing delivery momentum - a balance that takes real operational experience, not just theoretical knowledge.
